SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028339
Filing Date
2018-11-08
Accepted
2018-11-08 10:11:14
Documents
69
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-10q_20180930.htm 10-Q 2193367
2 EX-10.1 mcrb-ex101_188.htm EX-10.1 192721
3 EX-31.1 mcrb-ex311_8.htm EX-31.1 11511
4 EX-31.2 mcrb-ex312_9.htm EX-31.2 11488
5 EX-32.1 mcrb-ex321_6.htm EX-32.1 7649
6 EX-32.2 mcrb-ex322_7.htm EX-32.2 7688
  Complete submission text file 0001564590-18-028339.txt   7433708

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mcrb-20180930.xml EX-101.INS 1693954
8 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20180930.xsd EX-101.SCH 41516
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20180930_cal.xml EX-101.CAL 38768
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20180930_def.xml EX-101.DEF 148934
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20180930_lab.xml EX-101.LAB 310368
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20180930_pre.xml EX-101.PRE 270070
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 181168557
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences